Zobrazeno 1 - 10
of 60
pro vyhledávání: '"J Obergassel"'
Autor:
J Obergassel, C Al-Taie, M Remmel, S Taraba, L Rottner, J L Riess, M Nies, M Lemoine, F Ouyang, B Reissmann, P Kirchhof, A Metzner, A Rillig
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background Catheter ablation is the most effective rhythm control treatment for atrial fibrillation (AF). While it was indicated as a symptomatic treatment in the past years, prognostic benefits
Autor:
I My, S Bordignon, M Butt, L Rottner, M Lemoine, F Moser, J P Wenzel, J Obergassel, P Kirchhoff, B Reissmann, F Ouyang, K R J Chun, B Schmidt, A Rillig, A Metzner
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background A novel multi-electrode radiofrequency balloon (RFB) catheter has been released for pulmonary vein isolation (PVI). Objectives First multicenter real-world study to evaluate predictor
Autor:
M Lemoine, J Obergassel, L Rottner, F Moser, I My, J P Wenzel, J Moser, B Reissmann, F Ouyang, P Kirchhof, A Rillig, A Metzner
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background Pulsed-field ablation (PFA) integrated into a pentaspline catheter is a novel single shot device to perform pulmonary vein isolation (PVI) for treatment of atrial fibrillation (AF). W
Autor:
J Obergassel, C Al-Taie, M Remmel, M Lemoine, L Rottner, J L Riess, M Nies, B Reissmann, F Ouyang, A Metzner, P Kirchhof, A Rillig
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background Catheter ablation is the most effective rhythm control treatment for atrial fibrillation (AF) and benefits of early rhythm control (ERC) were recently demonstrated to be enhanced in p
Autor:
L Rottner, J Obergassel, K Borof, I My, F Moser, M Lemoine, J P Wenzel, P Kirchhof, F Ouyang, B Reissmann, A Metzner, A Rillig
Publikováno v:
Frontiers in Cardiovascular Medicine. 10
Funding Acknowledgements Type of funding sources: None. Background Cryoballoon (CB)- based pulmonary vein isolation (PVI) remains guided by fluoroscopy and dye. The novel saline injection-based occlusion tool allows for pulmonary vein (PV)-occlusion
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Heart Journal. 43
Type II Diabetes mellitus (T2DM) leads via hyperglycemia (HG)-associated inflammation and oxidative stress to vascular cell dysfunction. The EMPA-REG trial revealed a reduction of cardiovascular mortality in T2DM patients by Empagliflozin, a sodium-g
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J Obergassel, L Rottner, R Schleberger, F Moser, J Moser, L Dinshaw, MD Lemoine, I My, P Kirchhof, B Reissmann, A Metzner, A Rillig
Publikováno v:
EP Europace. 24
Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Study grant by EPD Solutions, Philips, Netherlands Background The occlusion tool was recently introduced for KODEX-EPD which is a novel dielectric high-resolut
Autor:
J Obergassel, S Taraba, M Nies, C Atzor, MD Lemoine, L Rottner, R Schleberger, LWH Dinshaw, C Meyer, S Willems, B Reissmann, F Ouyang, A Metzner, P Kirchhof, A Rillig
Publikováno v:
EP Europace. 24
Funding Acknowledgements Type of funding sources: None. Background Catheter ablation targeting isolation of the pulmonary veins (PVI) is the most effective treatment for atrial fibrillation (AF). Despite its high overall effectiveness, repeat AF abla